Developmental Regression-related Disease Research and Achievement Transformation Innovation Team

Launched by CHEN LI · Nov 23, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding why some children with autism spectrum disorder (ASD) and global developmental delay (GDD) experience developmental regression, which means they lose certain skills or abilities they had already developed. This can affect their learning and behavior, making it important to identify and support these children early on. The research team aims to find better ways to screen and diagnose children with these conditions, as well as explore potential genetic and treatment options that could help improve their outcomes and support their families.

To participate in the study, children must be between 1 to 7 years old and diagnosed with either ASD or GDD by qualified healthcare professionals. The trial is currently recruiting participants, and they will have the opportunity to contribute to important research that could lead to better understanding and treatments for developmental regression. It’s important to note that children with other significant mental or physical health issues, as well as those who have previously abused substances, will not be eligible to join this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • （1）ASD patients：
• • 1. Patients diagnosed with autism spectrum disorder based on DSM-5 by 2 child care physicians and/or psychiatrists with associate senior professional titles or above.
• • 2. Aged 1-7years
• • （2）DDpatients：
• • 1. Patients diagnosed with global developmental delay based on DSM-5 by 2 child care physicians and/or psychiatrists with associate senior professional titles or above.
• • 2. Aged 1-7 years
• Exclusion Criteria:
• • Exclude other histories of mental illness, neurological diseases and severe physical diseases, exclude patients with a history of substance and drug abuse, and patients who have not taken risperidone and other related antipsychotic drugs.